Skip to main content
The University of Arizona

Research Support and Funding: Valley Research Partnership

Local Funding Announcement

The Valley Research Partnership released a Request for Proposals to its Collaborative Research Program.  There are three funding mechanisms for eligible faculty, students, residents, and fellows.  The proposals can address a wide range of projects based at University of Arizona College of Medicine – Phoenix, Banner - University Medical Center Phoenix, and St. Joseph’s Hospital and Medical Center/Barrow Neurological Institute.  Please view the attached announcement and our web page at http://phoenixmed.arizona.edu/vrp for information.   

Valley Research Partnership Collaborative Research Program

- B -

Behbahaninia M, Martirosyan NL, Georges J, et al. Intraoperative fluorescent imaging of intracranial tumors: A review. Clin Neurol Neurosurg. 2013;115(5):517-528.

- G -

Georges JF, Liu X, Eschbacher J, et al. Use of a conformational switching aptamer for rapid and specific ex vivo identification of central nervous system lymphoma in a xenograft model. PLoS One. 2015;10(4):e0123607.

Georges JF, Martirosyan NL, Eschbacher J, et al. Sulforhodamine 101 selectively labels human astrocytoma cells in an animal model of glioblastoma. J Clin Neurosci. 2014;21(5):846-851.

- H -

Hu LS, Eschbacher JM, Dueck AC, et al. Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. AJNR Am J Neuroradiol. 2012;33(1):69-76.

Hu LS, Baxter LC, Pinnaduwage DS, et al. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol. 2010;31(1):40-48.

Hu LS, Eschbacher JM, Heiserman JE, et al. Reevaluating the imaging definition of tumor progression: Perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro Oncol. 2012;14(7):919-930.

- J -

Joy A, Ramesh A, Smirnov I, et al. AKT pathway genes define 5 prognostic subgroups in glioblastoma. PLoS One. 2014;9(7):e100827.

- R -

Rodriguez FJ, Tihan T, Lin D, et al. Clinicopathologic features of pediatric oligodendrogliomas: A series of 50 patients. Am J Surg Pathol. 2014;38(8):1058-1070.